Drug treatments to improve memory focus on enhancing acetylcholine. However, Vijayraghavan and colleagues (2018) show that direct stimulation of the M1 muscarinic acetylcholine receptor adversely affected neuronal activity in prefrontal cortex related to working memory for behavioral rules.
The neurotransmitter acetylcholine has long been accorded a critical role in memory and cognitive function. The observations of significant loss of cortical acetylcholine innervation in patients with Alzheimer's disease and the memory-impairing effects of anticholinergic drugs in healthy individuals informed the cholinergic hypothesis of geriatric memory dysfunction (Bartus 2000) . This hypothesis, that declines in cortical acetylcholine input in aging and dementia lead to impairments in memory, has directed the search for strategies to augment the cholinergic system to treat cognitive symptoms of dementia. Indeed, acetylcholinesterase inhibitors, which increase synaptic acetylcholine by inhibiting its enzymatic breakdown, have shown small but significant benefits in patients with Alzheimer's disease (Hampel et al., 2018) and are currently the main line of pharmacological therapy for Alzheimer's disease and other dementias.
Neuropathology in Alzheimer's disease is thought to begin decades before cognitive symptoms become apparent (Sperling et al., 2014) . Thus, even if effective diagnostic and preventative strategies were to be discovered today, there would still be a significant need for treatments of cognitive deficits resulting from already-entrenched neuropathology (Bartus 2000) . This underscores the critical urgency of understanding the nature of neuromodulation of cognitive function and the development of more effective drug therapies that can improve memory and cognition in individuals with dementia.
If the limited effectiveness of acetylcholinesterase inhibitors is because of ineffective dosing or side effects that constrain the beneficial impact of procholinergic therapy on the central nervous system, other strategies to modulate acetylcholine receptors might be beneficial. Direct stimulation of postsynaptic acetylcholine receptors has drawn interest in this regard (Lowe 2016). Such drugs could increase acetylcholine tone, perhaps rendering postsynaptic neurons more sensitive to input from intact cholinergic inputs and in this way relieving cognitive symptoms of dementia.
How would direct stimulation of postsynaptic muscarinic receptors affect neural systems involved in cognitive function? The prefrontal cortex is a key brain region in this regard, given its central role in many aspects of higher-order behavioral control and for representing and monitoring current behavioral goals and strategies. Moreover, the prefrontal cortex appears to possess unique neuromodulatory mechanisms that govern its representation of information in the absence of sensory input that is used to guide behavior (Arnsten et al., 2012) . In this issue of Neuron, Vijayraghavan and colleagues use an elegant combination of behavioral neurophysiology and iontophoretic application of specific pharmacological agents to interrogate the involvement of M1 muscarinic acetylcholine receptors in representation of behavioral rules by neurons in prefrontal cortex (Vijayraghavan et al., 2018) . In this study, monkeys are given a cue instructing them to look toward (prosaccade) or away from (antisaccade) a subsequently presented visual target, which can change on a trial-to-trial basis. In order to respond appropriately to the visual target, they are required to remember which rule is in effect on the current trial between the time the rule cue disappears and the target appears. The authors found-surprisingly, given many prominent views on the importance of cholinergic neuromodulation in working memory and in cognitive function more generally-that selective stimulation of M1 receptors suppressed prefrontal cortex neuronal activity and degraded rule representations at higher doses and that selective blockade of M1 receptors had inconsistent effects on rule selectivity. M1 antagonists had variable effects on prefrontal neuron activity and did not consistently affect activity related to working memory for rule. M1 agonists tended to inhibit prefrontal neurons, suppress population activity, and degrade selective activity related to memory for rules. These data are schematically summarized in Figure 1 . These findings argue against a straightforward role for modulation of postsynaptic M1 receptors on working memory representations in the prefrontal cortex. Stimulating postsynaptic M1 receptors tends to decrease activity of prefrontal neurons recorded during a working memory task and diminishes rather than enhances activity related to representation of specific rules in memory.
What are the implications of these findings for procognitive drug treatments for dementia? It is noteworthy that permanent ablation of basal forebrain cholinergic neurons does not recapitulate extensive memory impairments in many domains, although it may set the stage for more severe effects of structural lesions or disconnections of corticalsubcortical networks for memory (Croxson et al., 2012) . This may explain, at least in part, how structural damage to the basal forebrain in patients with Alzheimer's disease predicts the development of cortical pathology (Schmitz et al., 2016) , as degeneration of acetylcholine inputs to cortex compromises the capacity of networks for memory function to adapt to ongoing neurodegeneration. Even in the prefrontal cortex, where acetylcholine appears to play a unique and privileged role (Croxson et al., 2011; Major et al., 2015) , the present findings suggest that strategies aimed at stimulation of M1 receptors are unlikely to benefit prefrontal cortexdependent cognitive processes and may even make them worse.
Thus, caution is warranted for developing M1-directed drug therapies intended to augment prefrontal cortexdependent cognitive functions. It is a challenge to consider alternatives to a pharmacological strategy that has shown some benefit for cognitive impairments in Alzheimer's disease (Hampel et al., 2018) . As a target for drugs to improve cognitive function, acetylcholine is the devil we know. Attempts to develop more specific drugs targeting this system, even numbering a hundred times or more, may ultimately be limited by the synaptic mechanisms by which acetylcholine modulates cognitive function.
Figure 1. Schematic Diagram Illustrating the Effects of Selective M1 Receptor Stimulation and Blockade on Primate Prefrontal Cortex Neuronal Excitability and Working Memory Selectivity
(A) Drawing of the behavioral task chronology: monkeys viewed a cue (green or red) indicating whether they should look toward or away from a target stimulus that appeared after a short delay period. Trial rule selective activity during the delay period was associated with the specific rule in effect on that particular trial. Gray dots represent the fixation point (fix and delay) and the stimulus cue (stimulus). Green and red dots represent the pro-and antisaccade rule, respectively. (B) Iontophoretic application of M1 agonist (dark blue dots) inhibited more neurons (blue) than it excited (purple), with more neurons inhibited at higher doses of M1 agonist. Population activity was dosedependently suppressed by increasing M1 receptor stimulation (arrows). (C) Regardless of dose, iontophoretic application of M1 antagonist (yellow dots) also was more likely to inhibit than excite neurons. Population activity was modestly suppressed by increasing M1R blockade. In (B) and (C), percentages specify the proportions of neurons affected by drug application at low and high doses, and cartoons are scaled to illustrate the overall higher prevalence of inhibited (larger blue) versus stimulated (smaller purple) neurons. 
Zen and the Art of Making a Bayesian Espresso
Lei Zhang, 1 Sa sa Red zepovi c, 1 Michael Rose, 1 and Jan Gl€ ascher 1, * In this issue of Neuron, Konovalov and Krajbich (2018) argue that a Bayesian inference is employed when learning new sequences and identify distinct brain networks that track the uncertainty of both the current state and the underlying pattern structure.
''You look at where you're going and where you are and it never makes sense, but then you look back at where you've been and a pattern seems to emerge.''
Robert Pirsig, Zen and the Art of Motorcycle Maintenance
Our lives are shaped by rituals, little sequences of states and actions that give rhythm to our days. Preparing breakfast, driving to work, lunch with colleagues, getting groceries, and preparing dinner-a substantial amount of our behavior is driven by invariant scripts for specific situations. Here's the most treasured ritual of my morning: turning on the espresso machine, grinding the beans, smelling that scent of fresh coffee, tamping the grounds and adjusting the portafilter in the brew head, pulling the shot, seeing the crema rise in the cup, and finally tasting the first sip. I always repeat this sequence in the same way, and for me there is no better way to start the day. However, this ritual is also part of several longer sequences: preparing a latte, a cappuccino, or a flat white all include pulling a shot of espresso. For an outside observer, it is only in the course of the sequence that
it becomes clear what this final product will be. In the current issue of Neuron, Konovalov and Krajbich (2018) tackle the question of how our brains learn to detect deterministic sequences like the one above in the stream of sensory inputs. To this aim and in contrast to the classic serial reaction time task, which is commonly used to investigate implicit sequence learning (Nissen and Bullemer, 1987) , they employed a novel pattern detection task where subjects were instructed to predict upcoming stimuli in a stream of images. These images were configured as patterns of different lengths or no pattern ( Figure 1B) . A common finding in probabilistic (e.g., Bornstein and Daw, 2012) and deterministic sequence learning (e.g., Rose et al., 2010 ) is a sharp drop in reaction time (RT) that a participant needs to detect the next stimulus, indicating that the sequence has been learned. In the current study, RT drops serve as an indicator that a pattern of a certain length has been detected. In addition, each image was shown as an animation, starting with a scrambled version of all images from which the current image gradually emerges. This clever manipulation prolonged reaction times, leading to better detection of RT drops in each condition and hence to more meaningful and interpretable behavioral data. Indeed, Konovalov and Krajbich (2018) observed significant RT drops when they compared pattern against no pattern, and the effect also depended on the pattern lengths, as the RT drop occurred earlier for shorter sequences.
What accounts for this effect? One of the seminal contributions of their work is the hierarchical Bayesian pattern learning model, whereby individuals update their beliefs about both the structure (i.e., pattern length) and the state (i.e., upcoming image). The structure-level belief informs the state-level belief, guiding participants' prediction of the next image (face, F; house, H; or landscape, L), which differs for patterns of different lengths ( Figure 1A ). For example, if the observed image sequence F, L, F was part of a length-2 sequence, then L would be the prediction for the next image; if it was part of a length-3 sequence, then F would be the next predicted stimulus ( Figure 1B) . Depending on the structurelevel belief (is it a 2-or 3-length pattern?), the Bayesian learner would compute different state-level beliefs (is next image
